LIBRETTO-431: Selpercatinib in treatment-naive patients with RET fusion-positive non-small cell lung cancer (NSCLC) Meeting Abstract


Authors: Goto, K.; Wolf, J.; Elamin, Y.; Santini, F.; Soldatenkova, V.; Sashegyi, A.; Bence Lin, A.; Lin, B.; Novello, S.; Arriola Aperribay, E.; Perol, M.; Loong, H.; Drilon, A.; Park, K.; Solomon, B.; Zhou, C.
Abstract Title: LIBRETTO-431: Selpercatinib in treatment-naive patients with RET fusion-positive non-small cell lung cancer (NSCLC)
Meeting Title: 2020 World Conference on Lung Cancer
Keywords: non-small cell lung cancer; (nsclc); ret kinase inhibitor; trial in progress
Journal Title: Journal of Thoracic Oncology
Volume: 16
Issue: 3 Suppl.
Meeting Dates: 2021 Jan 28-31
Meeting Location: Singapore
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2021-03-01
Start Page: S228
End Page: S229
Language: English
ACCESSION: WOS:000631349600299
PROVIDER: wos
DOI: 10.1016/j.jtho.2021.01.148
Notes: Meeting Abstract: FP14.05 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon